SVA [SINOVAC BIOTECH] 6-K: Sinovac to Host Conference Call to Report Second

Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2015-08-13
Original SEC Filing: Click here


Webplus: SVA/20150813/6-K/2_EX-99.1/000.htm SEC Original: v418087_ex99-1.htm
Sinovac to Host Conference Call to Report Second Quarter 2015 Unaudited Financial Results · · Pageview: 1308 BEIJING, August 4, 2015 — Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, today announced that it will release its unaudited financial results for the second quarter, ended June 30, 2015, after market close on Wednesday, August 12,




Webplus: SVA/20150813/6-K/3_EX-99.2/000.htm SEC Original: v418087_ex99-2.htm
Sinovac Announces Results of 2015 Annual General Meeting of Shareholders · · Pageview: 447 BEIJING, August 11, 2015 /PRNewswire/ — Sinovac Biotech Ltd. (NASDAQ:SVA), a leading provider of biopharmaceutical products in China, today announced the results of the Company’s 2015 Annual General Meeting of Shareholders held on Tuesday, August 11, 2015 in Beijing, PRC. The required quorum, a majority of




Webplus: SVA/20150813/6-K/4_EX-99.3/000.htm SEC Original: v418087_ex99-3.htm
Sinovac Reports Unaudited Second Quarter Financial Results — Conference call scheduled for Thursday, August 13, 2015 at 8:00 AM ET · · Pageview: 254 BEIJING, Aug.12, 2015 /PRNewswire/ — Sinovac Biotech Ltd. (SVA), a leading provider of biopharmaceutical products in China, announced today its unaudited second quarter and half year financial results for the period ended June 30, 2015. Second




Webplus: SVA/20150813/6-K/1/000.htm SEC Original: v418087_6k.htm



Company Information:

Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2015-08-13CIK: 0001084201, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
39 SHANGDI XI ROAD
BEIJING 100085

Home Page Forums

By | 2016-03-16T06:25:05+00:00 August 13th, 2015|Categories: Chinese Stocks, SVA, Webplus ver|Tags: , , , , , |0 Comments

About the Author:

Leave A Comment

Skip to toolbar